Kras-mutant Solid Tumors
📧 Sign up to get email alerts when something new happens for Kras-mutant Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: TLN-372 in Advanced KRAS Mutant Solid Tumors [Phase 1]
Treeline Biosciences announced an ongoing Phase 1 trial of TLN-372 for advanced KRAS-mutant solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors [Phase 1]
Phase 1 trial evaluating NEROFE in combination with doxorubicin for KRAS-mutant ST2-positive solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation [Phase 1]
Phase 1 trial evaluating multiple doses of BI 1823911 alone and in combination for various advanced cancers with KRAS mutations; the study s…